Showing 1 - 6 results of 6 for search 'Todd N. Eagar', query time: 0.03s Refine Results
  1. 1
    Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.

    Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. by Matthew Cummings, Anitha Christy Sigamani Arumanayagam, Picheng Zhao, Sunil Kannanganat, Olaf Stuve, Nitin J Karandikar, Todd N Eagar

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing <italic toggle="yes">Klebsiella pneumoniae</italic> Isolates, Houston, Texas: Unexpected Abundance of Clonal Group 307

    Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing <italic toggle="yes">Klebsiella pneumoniae</italic> Isolates, Houston, Texas: Unexpected Abundance o... by S. Wesley Long, Randall J. Olsen, Todd N. Eagar, Stephen B. Beres, Picheng Zhao, James J. Davis, Thomas Brettin, Fangfang Xia, James M. Musser

    Published 2017-07-01
    Get full text
    Article
  3. 3
    PEG minocycline-liposomes ameliorate CNS autoimmune disease.

    PEG minocycline-liposomes ameliorate CNS autoimmune disease. by Wei Hu, Josbert Metselaar, Li-Hong Ben, Petra D Cravens, Mahendra P Singh, Elliot M Frohman, Todd N Eagar, Michael K Racke, Bernd C Kieseier, Olaf Stüve

    Published 2009-01-01
    Get full text
    Article
  4. 4
    A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.

    A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR. by Benjamine Arellano, Rehana Hussain, William A Miller-Little, Emily Herndon, Doris Lambracht-Washington, Todd N Eagar, Robert Lewis, Don Healey, Steven Vernino, Benjamin M Greenberg, Olaf Stüve

    Published 2016-01-01
    Get full text
    Article
  5. 5
    Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.

    Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. by Nancy L Monson, Petra Cravens, Rehana Hussain, Christopher T Harp, Matthew Cummings, Maria de Pilar Martin, Li-Hong Ben, Julie Do, Jeri-Anne Lyons, Amy Lovette-Racke, Anne H Cross, Michael K Racke, Olaf Stüve, Mark Shlomchik, Todd N Eagar

    Published 2011-02-01
    Get full text
    Article
  6. 6
    Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy

    Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy by Abhinay Gontu, Sreenidhi Srinivasan, Eric Salazar, Meera Surendran Nair, Ruth H. Nissly, Denver Greenawalt, Ian M. Bird, Catherine M. Herzog, Matthew J. Ferrari, Indira Poojary, Robab Katani, Scott E. Lindner, Allen M. Minns, Randall Rossi, Paul A. Christensen, Brian Castillo, Jian Chen, Todd N. Eagar, Xin Yi, Picheng Zhao, Christopher Leveque, Randall J. Olsen, David W. Bernard, Jimmy Gollihar, Suresh V. Kuchipudi, James M. Musser, Vivek Kapur

    Published 2021-02-01
    Get full text
    Article

Search Tools: